The debate over soaring health care costs fails to properly acknowledge the benefits that have stemmed from improved medical technology and expanded medical knowledge, said Triological Society President Gerald Berke, MD, in an address at the society’s Combined Sections Meeting, held here on Jan. 27.
The newly adopted clinical practice guidelines (CPG) on hoarseness—and concerns that portions are overly simplistic and could harm care—took center stage here in a panel discussion at the Annual Meeting of the American Society of Pediatric Otolaryngology, part of the Combined Otolaryngology Spring Meetings held here April 28-May 2.
Dr. Roberts used numbers to illustrate his point during a presentation at the Annual Meeting of the American Broncho-Esophagological Association, part of the Combined Otolaryngological Spring Meetings held here April 28-May 2.
A test that measures in real time how a noise stimulus on one side affects contralateral otoacoustic emissions (OAEs) could be a new, more accurate predictor of hearing in newborns, according to award-winning research presented at the Annual Meeting of the Triological Society, part of the Combined Otolaryngology Spring Meetings held here April 28-May 2.
An airway clinic jointly staffed by an otolaryngologist and a pulmonologist in Salt Lake City acts as a model for the future care of airway disorders, according to a presentation given at the Annual Meeting of the American Broncho-Esophagological Association (ABEA), part of the Combined Otolaryngology Spring Meetings (COSM) held here April 28-May 2.
Since the advent of the cochlear implant more than 20 years ago, the devices have benefited thousands of patients. According to the U.S. Food and Drug Administration, as of April 2009, approximately 188,000 people worldwide have received cochlear implants. In the U.S., about 42,000 adults and 26,000 children have received them. Today, the fantasy of two implanted artificial cochlea is a reality.
Each month, Product Watch offers readers the latest information on new and innovative products for otolaryngologists-head and neck surgeons.
The largest survey to date of patients with allergic rhinitis (AR) and physicians who treat them revealed that patients’ and physicians’ perceptions of this disorder are not always in sync.
Even in patients with relatively common sinus disease, decision making about endoscopic sinus surgery (ESS) can be difficult, and not all cases are the same.
A new era in efforts to treat patients with tissue loss or organ failure is under way, which has the potential to revolutionize the treatment of many diseases and conditions that otolaryngologists treat.